SCHEMBL1865417

SCHEMBL1865417

CC1Cc2ccccc2N1C(=O)NC1CCCCCCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
NOTUM Q6P988 1/20 0.58
TSHR P16473 3/20 0.56
RAB9A P51151 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
NPC1 O15118 1/20 0.56
PKM P14618 1/20 0.56
ALDH1A1 P00352 4/20 0.53
MAPT P10636 2/20 0.53
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
P2RX1 P51575 1/20 0.52
P2RX3 P56373 1/20 0.52
P2RX4 Q99571 1/20 0.52
P2RX7 Q99572 1/20 0.52
BCHE P06276 2/20 0.51
POLB P06746 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1861699 1.00 LMNA (0.59) LMNAMEN1KMT2ANOTUMTSHR
SCHEMBL1867501 1.00 LMNA (0.59) LMNAMEN1KMT2ANOTUMTSHR
SCHEMBL1865415 1.00 LMNA (0.59) LMNAMEN1KMT2ANOTUMTSHR
SCHEMBL1865452 1.00 LMNA (0.59) LMNAMEN1KMT2ANOTUMTSHR
SCHEMBL13276088 1.00 LMNA (0.59) LMNAMEN1KMT2ANOTUMTSHR
SCHEMBL10362088 0.82 NOTUM (0.53) LMNANOTUMTSHRRAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL7438226 0.81 NOTUM (0.52) LMNANOTUMTSHRPKMALDH1A1
SCHEMBL1867247 0.81 PKM (0.62) LMNAMEN1KMT2ANOTUMTSHR
SCHEMBL10859231 0.80 NOTUM (0.69) LMNAMEN1KMT2ANOTUMTSHR
SCHEMBL20462830 0.75 NOTUM (0.75) LMNAMEN1KMT2ANOTUMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120263848-A1 Organic Compounds GIVAUDAN SA (CH) 2012-10-18 US claimed
EP-2493853-A1 ORGANIC COMPOUNDS Givaudan SA (CH) 2012-09-05 EP claimed
WO-2011051394-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2011-05-05 WO claimed
US-20120263848-A1 Organic Compounds GIVAUDAN SA (CH) 2012-10-18 US disclosed
US-20120263848-A1 Organic Compounds GIVAUDAN SA (CH) 2012-10-18 US disclosed
US-20120263848-A1 Organic Compounds GIVAUDAN SA (CH) 2012-10-18 US disclosed
EP-2493853-A1 ORGANIC COMPOUNDS Givaudan SA (CH) 2012-09-05 EP disclosed
WO-2011051394-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2011-05-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120263848-A1 Organic Compounds OR10J3, CBR3, C9 LMNA 3667/4885MEN1 2467/4885KMT2A 2862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.